Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3019253)

Published in Exp Neurol on November 17, 2010

Authors

Gary Leung1, Wenjing Sun, Sarah Brookes, Daniel Smith, Riyi Shi

Author Affiliations

1: Department of Basic Medical Sciences, Center for Paralysis Research, Purdue University, West Lafayette, IN 47907, USA.

Articles cited by this

Multiple sclerosis. Lancet (2008) 13.77

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet (2009) 3.51

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain (2006) 3.51

Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol (2005) 2.02

Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres. Nature (1980) 1.71

Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature (1980) 1.62

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron (2004) 1.46

Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience (1997) 1.20

Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience (2000) 1.05

Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma. Eur J Neurosci (2004) 1.04

Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull (1989) 1.03

Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. J Neurophysiol (1996) 1.03

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma (1998) 1.02

Conduction deficits and membrane disruption of spinal cord axons as a function of magnitude and rate of strain. J Neurophysiol (2006) 1.01

Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. J Neurophysiol (2009) 1.00

Abnormal axonal physiology is associated with altered expression and distribution of Kv1.1 and Kv1.2 K+ channels after chronic spinal cord injury. Eur J Neurosci (2000) 1.00

Characterization of 4-aminopyridine in overdose. J Toxicol Clin Toxicol (1994) 0.99

Relationships among seizures, extracellular amino acid changes, and neurodegeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study. J Neurochem (1999) 0.98

Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. J Neurophysiol (2003) 0.97

Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery? J Neurotrauma (1992) 0.92

The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. J Neurotrauma (1991) 0.90

Sustained-release fampridine for symptomatic treatment of multiple sclerosis. Ann Pharmacother (2008) 0.89

Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp Neurol (1997) 0.87

Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury. Prog Brain Res (1994) 0.85

4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J Neurotrauma (1994) 0.85

Effect of 4-aminopyridine in acute spinal cord injury. Surg Neurol (1995) 0.81

Articles by these authors

Coherent anti-stokes Raman scattering imaging of axonal myelin in live spinal tissues. Biophys J (2005) 3.62

ASRP: the Arabidopsis Small RNA Project Database. Nucleic Acids Res (2005) 3.46

The 2006 California heat wave: impacts on hospitalizations and emergency department visits. Environ Health Perspect (2008) 3.27

Evaluation of potential renal transplant recipients with computed tomography angiography. Arch Surg (2012) 2.07

Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med (2011) 1.76

Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem (2007) 1.71

Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell (2013) 1.71

The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci (2010) 1.65

Entertainment-education in the context of humor: effects on safer sex intentions and risk perceptions. Health Commun (2011) 1.59

Clinical differences between bipolar and unipolar depression. Br J Psychiatry (2008) 1.58

Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation. J Biol Chem (2009) 1.56

DJ-1 may contribute to metastasis of non-small cell lung cancer. Mol Biol Rep (2011) 1.52

Traffic patterns and childhood cancer incidence rates in California, United States. Cancer Causes Control (2002) 1.52

Characterization of photodamage in coherent anti-Stokes Raman scattering microscopy. Opt Express (2006) 1.46

Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. J Biol Chem (2009) 1.43

Risk of autism and increasing maternal and paternal age in a large north American population. Am J Epidemiol (2009) 1.42

Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium-dependent pathway in lyso-PtdCho-induced demyelination. J Neurosci Res (2007) 1.39

Regional variations in breast cancer incidence among California women, 1988-1997. Cancer Causes Control (2005) 1.39

Prevalence and mental health correlates of witnessed parental and community violence in a national sample of adolescents. J Child Psychol Psychiatry (2008) 1.32

Pesticides in dust from homes in an agricultural area. Environ Sci Technol (2009) 1.31

Second harmonic and sum frequency generation imaging of fibrous astroglial filaments in ex vivo spinal tissues. Biophys J (2007) 1.28

Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J Neurochem (2002) 1.24

Direct analysis of biological tissue by paper spray mass spectrometry. Anal Chem (2011) 1.23

Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J Biol Chem (2008) 1.23

Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction. PLoS One (2009) 1.17

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study. BMC Musculoskelet Disord (2004) 1.17

Acrolein induces oxidative stress in brain mitochondria. Neurochem Int (2004) 1.15

Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J Neurochem (2008) 1.15

Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int (2005) 1.13

Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nat Nanotechnol (2009) 1.12

Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem Int (2004) 1.11

Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem (2009) 1.11

Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem Res (2005) 1.11

Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer (2011) 1.10

Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma (2004) 1.08

Acrolein-mediated mechanisms of neuronal death. J Neurosci Res (2006) 1.08

Acrolein induces myelin damage in mammalian spinal cord. J Neurochem (2011) 1.07

A simple method for estimating excess mortality due to heat waves, as applied to the 2006 California heat wave. Int J Public Health (2009) 1.07

Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J Neurochem (2007) 1.07

Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J Exp Biol (2010) 1.06

Hydralazine rescues PC12 cells from acrolein-mediated death. J Neurosci Res (2006) 1.06

Analysis of conditional mutations in the Saccharomyces cerevisiae MLH1 gene in mismatch repair and in meiotic crossing over. Genetics (2002) 1.05

Acrolein-mediated injury in nervous system trauma and diseases. Mol Nutr Food Res (2011) 1.05

Compression induces acute demyelination and potassium channel exposure in spinal cord. J Neurotrauma (2010) 1.00

Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J Exp Biol (2002) 1.00

Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. J Neurophysiol (2009) 1.00

Detection of reactive oxygen species by flow cytometry after spinal cord injury. J Neurosci Methods (2002) 1.00

Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials (2003) 0.99

Health status in long-term survivors of pediatric craniopharyngiomas. J Neurosci Nurs (2010) 0.99

Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development. J Med Chem (2009) 0.98

Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma. Mol Biol Rep (2008) 0.97

Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms. J Biol Chem (2012) 0.97

Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. J Neurophysiol (2003) 0.97

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.95

Adhesive strength of marine mussel extracts on porcine skin. Biomaterials (2003) 0.95

Polyethylene glycol rapidly restores physiological functions in damaged sciatic nerves of guinea pigs. Neurosurgery (2002) 0.94

Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells. PLoS One (2013) 0.94

Longitudinal in vivo coherent anti-Stokes Raman scattering imaging of demyelination and remyelination in injured spinal cord. J Biomed Opt (2011) 0.94

National Athletic Trainers' Association position statement: environmental cold injuries. J Athl Train (2008) 0.94

Impact of the plant rhizosphere and augmentation on remediation of polychlorinated biphenyl contaminated soil. Environ Toxicol Chem (2003) 0.93

Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J Exp Biol (2007) 0.93

Subtle paranodal injury slows impulse conduction in a mathematical model of myelinated axons. PLoS One (2013) 0.93

Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. Eur J Med Chem (2005) 0.93

Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation. J Biol Chem (2009) 0.92

α-Enolase, an adhesion-related factor of Mycoplasma bovis. PLoS One (2012) 0.92

Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage. J Neurochem (2013) 0.92

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression. Pharmacogenet Genomics (2007) 0.91

Paranodal myelin damage after acute stretch in Guinea pig spinal cord. J Neurotrauma (2011) 0.90

Functional silica nanoparticle-mediated neuronal membrane sealing following traumatic spinal cord injury. J Neurosci Res (2010) 0.90

Near fatal posterior reversible encephalopathy syndrome complicating chronic liver failure and treated by induced hypothermia and dialysis: a case report. J Med Case Rep (2009) 0.90

Determination of urine 3-HPMA, a stable acrolein metabolite in a rat model of spinal cord injury. J Neurotrauma (2013) 0.90

Real-time CARS imaging reveals a calpain-dependent pathway for paranodal myelin retraction during high-frequency stimulation. PLoS One (2011) 0.90

Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res (2007) 0.90

Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomedicine (Lond) (2008) 0.89

Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons. Neurosci Bull (2011) 0.89

Biomechanics of spinal cord injury: a multimodal investigation using ex vivo guinea pig spinal cord white matter. J Neurotrauma (2008) 0.89

Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32). J Affect Disord (2008) 0.89

Both egocentric and allocentric cues support spatial priming in visual search. Neuropsychologia (2008) 0.89

Repairing the damaged spinal cord and brain with nanomedicine. Small (2008) 0.88

Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion (2011) 0.88

Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries. Biomacromolecules (2010) 0.88

Adhesive strength and curing rate of marine mussel protein extracts on porcine small intestinal submucosa. Acta Biomater (2007) 0.87

The N170, not the P1, indexes the earliest time for categorical perception of faces, regardless of interstimulus variance. Neuroimage (2012) 0.87

PPM1B negatively regulates antiviral response via dephosphorylating TBK1. Cell Signal (2012) 0.86

Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control (2003) 0.86

Stretch-induced nerve conduction deficits in guinea pig ex vivo nerve. J Biomech (2006) 0.86

Tetrafluoro-IBA and-IBX: hypervalent iodine reagents. Angew Chem Int Ed Engl (2007) 0.86

Fabrication of patterned multi-walled poly-l-lactic acid conduits for nerve regeneration. J Neurosci Methods (2007) 0.86

The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus. Gene (2012) 0.86

New insights in the pathogenesis of multiple sclerosis--role of acrolein in neuronal and myelin damage. Int J Mol Sci (2013) 0.85

Development of a mass spectrometry sampling probe for chemical analysis in surgical and endoscopic procedures. Anal Chem (2013) 0.85

Polyethylene glycol enhances axolemmal resealing following transection in cultured cells and in ex vivo spinal cord. J Neurotrauma (2010) 0.84

Functional and mechanical evaluation of nerve stretch injury. J Med Syst (2010) 0.84

Mutagenic analysis of Cox11 of Rhodobacter sphaeroides: insights into the assembly of Cu(B) of cytochrome c oxidase. Biochemistry (2010) 0.84

Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive. Acta Biomater (2012) 0.84